Journal of Renal Nutrition
Volume 14, Issue 2 , Pages 72-81 , April 2004

The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis

  • George A Kaysen, MD, PhD

      Affiliations

    • Division of Nephrology, Department of Medicine, University of California Davis, Davis, CA, USA
    • ,
  • Hans-Georg Müller, MD, PhD

      Affiliations

    • Department of Statistics, University of California Davis, Davis, CA, USA
    • ,
  • Belinda S Young, MSPH

      Affiliations

    • Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    • ,
  • Xiaoyan Leng, MS

      Affiliations

    • Department of Statistics, University of California Davis, Davis, CA, USA
    • ,
  • Glenn M Chertow, MD, MPH

      Affiliations

    • Division of Nephrology, Departments of Medicine and Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
    • Corresponding Author InformationAddress reprint requests to Glenn M. Chertow, MD, MPH, University of California San Francisco, Department of Medicine Research, UCSF Laurel Heights Suite 430, 3333 California Street, San Francisco, CA 94118-1211 USA

References 

  1. Lowrie E, Lew N. Death risk in hemodialysis patients (The predictive value of commonly measured variables and an evaluation of death rate differences between facilities). Am J Kidney Dis. 1990;15:458–482
  2. Salahudeen AK, Dykes P, May W. Risk factors for higher mortality at the highest levels of spKt/V in haemodialysis patients. Nephrol Dial Transplant. 2003;18:1339–1344
  3. Owen WF, Chertow GM, Lazarus JM, et al.  Dose of hemodialysis and survival (Differences by race and sex). JAMA. 1998;280:1764–1768
  4. McClellan WM, Flanders WD, Gutman RA. Variable mortality rates among dialysis treatment centers. Ann Int Med. 1992;117:332–335
  5. Eknoyan G, Beck GJ, Cheung AK, et al.  Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–2019
  6. Lunde AV, Barrett-Connor E, Morton DJ. Serum albumin and bone mineral density in healthy older men and women (The Rancho Bernardo Study). Osteoporos Int. 1998;8:547–551
  7. Feldman HI, Bilker WB, Hackett MH, et al.  Association of dialyzer reuse with hospitalization and survival rates among U.S. hemodialysis patients (Do comorbidities matter?). J Clin Epidemiol. 1999;52:209–217
  8. Held PJ, Wolfe RA, Gaylin DS, et al.  Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis. 1994;23:692–708
  9. Lindsay RM, Blake PG, Malek P, et al.  Hemodialysis access blood flow rates can be measured by a differential conductivity technique and are predictive of access clotting. Am J Kidney Dis. 1997;30:475–482
  10. Schwab SJ, Oliver MJ, Suhocki P, et al.  Hemodialysis arteriovenous access (Detection of stenosis and response to treatment by vascular access blood flow). Kidney Int. 2001;59:358–362
  11. Tonelli M, Hirsch D, Clark TW, et al.  Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplasty. J Am Soc Nephrol. 2002;13:2969–2973
  12. Daugirdis JT, Blake PG, Ing TS. Handbook of Dialysis. Philadelphia: Lippincott Williams and Wilkins; 2001;
  13. In:  Bonomini V,  Berland Y editor. Dialysis Membranes: Structure and Predictions. Contrib Nephrol, vol 113, pp 11–24 (Composition of Polymer Membranes for Therapies of End-Stage Renal Disease). Basel: Karger; 1995;
  14. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc B. 1972;34:187–220
  15. Lonnemann G, Bingel M, Koch KM, et al.  Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res. 1987;6:63–70
  16. Ingenbleek Y, De Visscher M, De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet. 1972;7768:106–109
  17. Rigaud D, Hassid J, Meulemans A, et al.  A paradoxical increase in resting energy expenditure in malnourished patients near death (The king penguin syndrome). Am J Clin Nutr. 2000;72:355–360
  18. Moldawer LL, Copeland EM. Proinflammatory cytokines, nutritional support, and the cachexia syndrome (Interactions and therapeutic options). Cancer. 1997;79:1828–1839
  19. Michie HR. Metabolism of sepsis and multiple organ failure. World J Surg. 1996;20:460–464
  20. Kaplan AA, Halley SE, Lapkin RA, et al.  Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int. 1995;47:573–578
  21. Li YP, Lecker SH, Chen Y, et al.  TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J. 2003;17:1048–1057
  22. Guttridge DC, Mayo MW, Madrid LV, et al.  NF-κB-induced loss of MyoD messenger RNA (Possible role in muscle decay and cachexia). Science. 2000;289:2363–2366
  23. Wang ZM, Sun YG, Heymsfield SB. Urinary creatinine-skeletal muscle mass method (A prediction equation based on computerized axial tomography). Biomed Environ Sci. 1996;9:185–190
  24. Tielemans C, Husson C, Schurmans T, et al.  Effects of ultrapure and nonsterile dialysate on the inflammatory response during in vitro hemodialysis. Kidney Int. 1996;49:236–243
  25. Bambauer R, Walther J, Jung WK. Ultrafiltration of dialysis fluid to obtain a sterile solution during hemodialysis. Blood Purif. 1990;8:309–317
  26. Bambauer R, Schmidt R, Falkenhagen D, et al.  Sterile and endotoxin free dialysis fluid for hemodialysis. Biomater Artif Cells Immob Biotechnol. 1991;19:71–83
  27. Reddan D, Klassen P, Frankenfield DL, et al.  National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol. 2002;13:2117–2124
  28. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620–626
  29. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60:1–13
  30. Depner TA. Catheter performance. Semin Dial. 2001;14:425–431
  31. Wu TL, Tsao KC, Chang CP, et al.  Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin Chim Acta. 2002;322:163–168
  32. Chertow GM, Owen WF, Lazarus JM, et al.  Exploring the J-shaped relation curve between URR and mortality. Kidney Int. 1999;56:1872–1878
  33. Wang ZM, Sun YG, Heymsfield SB. Urinary creatinine-skeletal muscle mass method (A prediction equation based on computerized axial tomography). Biomed Environ Sci. 1996;9:185–190
  34. Heymsfield SB, Arteaga C, McManus C, et al.  Measurement of muscle mass in humans (Validity of the 24-hour urinary creatinine method). Am J Clin Nutr. 1983;37:478–494
  35. Kaysen GA, Chertow GM, Adhikarla R, et al.  Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int. 2001;60:333–340
  36. Kaysen GA, Dubin JA, Muller HG, et al.  The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int. 2000;58:346–352
  37. Brink M, Anwar A, Delafontaine P. Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia. Int J Cardiol. 2002;85:111–121
  38. Losito A, Kalidas K, Santoni S, et al.  Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int. 2003;64:616–622
  39. Girndt M, Kaul H, Sester U, et al.  Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 2002;62:949–955
  40. Jenny NS, Tracy RP, Ogg MS, et al.  In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:2066–2071
  41. Flex A, Gaetani E, Pola R, et al.  The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 2002;24:264–268

☆ Supported by contract N01-DK-1-2450 from the National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases.

PII: S1051-2276(04)00007-X

doi: 10.1053/j.jrn.2004.01.006

Journal of Renal Nutrition
Volume 14, Issue 2 , Pages 72-81 , April 2004

Article Tools

* Image Usage & Resolution